IRIS
STOLFI, CARMINE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 18.746
EU - Europa 1.432
AS - Asia 351
SA - Sud America 6
AF - Africa 2
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 1
Totale 20.540
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 18.736
IT - Italia 245
DE - Germania 236
IE - Irlanda 235
UA - Ucraina 226
CN - Cina 213
SE - Svezia 136
GB - Regno Unito 107
KR - Corea 96
FR - Francia 77
FI - Finlandia 53
RU - Federazione Russa 39
PL - Polonia 35
BE - Belgio 20
HK - Hong Kong 9
JP - Giappone 7
CA - Canada 5
IN - India 5
ES - Italia 4
RO - Romania 4
SG - Singapore 4
BR - Brasile 3
CH - Svizzera 3
CL - Cile 3
DM - Dominica 3
GR - Grecia 3
IR - Iran 3
TR - Turchia 3
DK - Danimarca 2
EU - Europa 2
IL - Israele 2
MK - Macedonia 2
MX - Messico 2
NL - Olanda 2
NO - Norvegia 2
AT - Austria 1
AU - Australia 1
BD - Bangladesh 1
BT - Bhutan 1
EG - Egitto 1
ID - Indonesia 1
KG - Kirghizistan 1
LB - Libano 1
MA - Marocco 1
PH - Filippine 1
SA - Arabia Saudita 1
TW - Taiwan 1
VN - Vietnam 1
Totale 20.540
Salva come PNG Salva come JPEG
Città #
Woodbridge 5.255
Wilmington 4.781
Houston 4.525
Fairfield 815
Chandler 480
Ann Arbor 472
Ashburn 398
Seattle 316
Cambridge 286
Dublin 213
Jacksonville 208
Medford 169
Dearborn 127
Rome 126
New York 97
Beijing 96
Lawrence 75
San Diego 46
Kraków 34
Zhengzhou 34
Menlo Park 28
Mülheim 26
Brussels 20
London 20
Seoul 17
Redwood City 15
Boardman 14
Hangzhou 14
Mountain View 13
Colorado Springs 12
Milan 12
Palo Alto 11
Norwalk 10
Shanghai 10
Nanjing 8
San Mateo 8
Guangzhou 7
Kilburn 7
Saint Petersburg 7
Verona 7
Council Bluffs 6
North Hollywood 6
Nürnberg 6
University Park 6
Cedarhurst 5
Creede 5
Hanover 5
Helsinki 5
Auburn Hills 4
Bari 4
Chengdu 4
Del Norte 4
Duncan 4
Falls Church 4
Hefei 4
Nanchang 4
Nepi 4
Atlanta 3
Chicago 3
Fuzhou 3
Indiana 3
Lappeenranta 3
Prescot 3
Pune 3
Roseau 3
Shenyang 3
Tokyo 3
Toronto 3
Washington 3
Aarhus 2
Adana 2
Center 2
Durham 2
Engelhard 2
Florence 2
Hong Kong 2
Hounslow 2
Ivry-sur-seine 2
Jinan 2
Kunming 2
Lausanne 2
Licata 2
Los Angeles 2
Mentana 2
Napoli 2
Omaha 2
Quzhou 2
San Francisco 2
São Paulo 2
Tehran 2
Urgnano 2
Veroli 2
Wandsworth 2
Yellow Springs 2
Acqualagna 1
Acton 1
Amsterdam 1
Augusta 1
Baotou 1
Barcelona 1
Totale 18.991
Salva come PNG Salva come JPEG
Nome #
2-Methoxy-5-Amino-N-Hydroxybenzamide Sensitizes Colon Cancer Cells to TRAIL-Induced Apoptosis by Regulating Death Receptor 5 and Survivin Expression 462
2-Methoxy-5-amino-N-hydroxybenzamide, a derivative of mesalamine, inhibits colon cancer cell growth through cyclo-oxygenase-2-dependent and -independent mechanisms 453
Defective expression of SIRT1 contributes to sustain inflammatory pathways in the gut 440
Involvement of interleukin-21 in the epidermal hyperplasia of psoriasis 438
Transcriptional and post-translational regulation of Flip, an inhibitor of Fas-mediated apoptosis, in human gut inflammation 429
A functional role for Smad7 in sustaining colon cancer cell growth and survival 428
Smad7 induces plasticity in tumor-infiltrating Th17 cells and enables TNF-alpha-mediated killing of colorectal cancer cells 422
High expression of the "A Disintegrin And Metalloprotease" 19 (ADAM19), a sheddase for TNF-α in the mucosa of patients with inflammatory bowel diseases 420
Interleukin-25 Inhibits Interleukin-12 Production and Th1 Cell-Driven Inflammation in the Gut 418
Regulation of gut inflammation and Th17 cell response by interleukin-21 417
Cyclooxygenase-2-dependent and -independent inhibition of proliferation of colon cancer cells by 5-aminosalicylic acid 415
The dual role of Smad7 in the control of cancer growth and metastasis 414
Lactobacillus paracasei subsp paracasei B21060 suppresses human T-cell proliferation 407
Th17-type cytokines, IL-6 and TNF-α synergistically activate STAT3 and NF-kB to promote colorectal cancer cell growth 406
Smad7 Expression in T cells Prevents Colitis-Associated Cancer 405
IL-21 Promotes Skin Recruitment of CD4+ Cells and Drives IFN- -Dependent Epidermal Hyperplasia 402
Autocrine regulation of IL-21 production in human T lymphocytes 401
Colorectal cancer chemoprevention by mesalazine and its derivatives 401
Inhibition of colon carcinogenesis by 2-methoxy-5-amino-N-hydroxybenzamide, a novel derivative of mesalamine 400
The Dual Role of Interleukin-25 in the Control of Immune-Mediated Pathologies 400
Control of matrix metalloproteinase production in human intestinal fibroblasts by interleukin 21 397
Inhibition of monocyte-derived inflammatory cytokines by IL-25 occurs via p38 Map kinase-dependent induction of Socs-3 396
Molecular Targets of TRAIL-Sensitizing Agents in Colorectal Cancer 395
Protease-activated receptor-2 activation in gastric cancer cells promotes epidermal growth factor receptor trans-activation and proliferation 394
Peritoneal expression of matrilysin helps identify early post-operative recurrence of colorectal cancer 393
Collagen matrix injection combined with flap repair for complex anal fistula 384
The dual role of inflammation in colon carcinogenesis 383
Mechanisms of action of non-steroidal anti-inflammatory drugs (NSAIDs) and mesalazine in the chemoprevention of colorectal cancer 383
A functional role for interleukin-21 in promoting the synthesis of the T-cell chemoattractant, MIP-3 alpha, by gut epithelial cells 382
Inhibition of colitis by IL-25 associates with induction of alternatively activated macrophages 379
IL-23-mediated regulation of IL-17 production in Helicobacter pylori-infected gastric mucosa 378
Involvement of interleukin-21 in the regulation of colitis-associated colon cancer 378
Role of TH17 cytokines in the control of colorectal cancer 371
Detection methods and clinical significance of free peritoneal tumor cells found during colorectal cancer surgery. 370
Interleukin-25 fails to activate STAT6 and induce alternatively activated macrophages 366
Mesalazine negatively regulates CDC25A protein expression and promotes accumulation of colon cancer cells in S phase 355
The tumor suppressor activity of IKK alpha in stratified epithelia is exerted in part via the TGF-beta anti proliferative pathway 353
Smad7 Controls Resistance of Colitogenic T Cells to Regulatory T Cell-Mediated Suppression 350
Molecular basis of the potential of mesalazine to prevent colorectal cancer 347
Interleukin-21 sustains inflammatory signals that contribute to sporadic colon tumorigenesis 345
Smad7 positively regulates keratinocyte proliferation in psoriasis 321
Lesional accumulation of CD163-expressing cells in the gut of patients with inflammatory bowel disease 312
Interleukin-21 in cancer immunotherapy: Friend or foe? 308
IL-21 is highly produced in Helicobacter pylori-infected gastric mucosa and promotes gelatinases synthesis 307
The Food Additive Maltodextrin Promotes Endoplasmic Reticulum Stress–Driven Mucus Depletion and Exacerbates Intestinal Inflammation 295
Interleukin-34 sustains pro-tumorigenic signals in colon cancer tissue 289
Smad7 knockdown activates protein kinase RNA-associated eIF2α pathway leading to colon cancer cell death 280
Interleukin-34 sustains pro-tumorigenic signals in colon cancer tissue 267
Interferon-gamma-expressing cells are a major source of interleukin-21 in inflammatory bowel diseases 260
Tbet Expression in Regulatory T Cells Is Required to Initiate Th1-Mediated Colitis 184
Induction of endoplasmic reticulum stress and inhibition of colon carcinogenesis by the anti-helmintic drug rafoxanide 180
Progranulin sustains STAT3 hyper-activation and oncogenic function in colorectal cancer cells 164
NPD-0414-2 and NPD-0414-24, two chemical entities designed as aryl hydrocarbon receptor (AHR) ligands, inhibit gut inflammatory signals 151
Neutrophil extracellulartraps sustain inflammatory signals in ulcerative colitis 140
Molecular targets of mesalazine in colorectal cancer 125
Metformin inhibits inflammatory signals in the gut by controlling AMPK and p38 MAP kinase activation 115
Rafoxanide Induces Immunogenic Death of Colorectal Cancer Cells 108
{STAT}3 Interactors as Potential Therapeutic Targets for Cancer Treatment 104
Follistatin-like protein 1 sustains colon cancer cell growth and survival 83
null 78
The fragile X mental retardation protein regulates RIP1K and colorectal cancer resistance to necroptosis 68
Association Between Celiac Disease and Cancer 64
Repositioning of Anthelmintic Drugs for the Treatment of Cancers of the Digestive System 59
NPD-0414-2 and NPD-0414-24, Two Chemical Entities Designed as Aryl Hydrocarbon Receptor (AhR) Ligands, Inhibit Gut Inflammatory Signals 59
RORγt-Expressing tregs drive the growth of colitis-associated colorectal cancer by controlling IL6 in dendritic cells 54
Role of interleukin-34 in cancer 46
Transforming Growth Factor-β1/Smad7 in Intestinal Immunity, Inflammation, and Cancer 45
BRAFV600E cooperates with CDX2 inactivation to promote serrated colorectal tumorigenesis 42
Combined and selective miR-21 silencing and doxorubicin delivery in cancer cells using tailored DNA nanostructures 40
Aptamer linked to DNA nanostructures diverts its traffic inside cancer cells and improves its therapeutic efficacy 40
GATA6 Deficiency Leads to Epithelial Barrier Dysfunction and Enhances Susceptibility to Gut Inflammation 37
The Fragile X Mental Retardation Protein Regulates RIPK1 and Colorectal Cancer Resistance to Necroptosis 35
The AtMYB11 gene from Arabidopsis is expressed in meristematic cells and modulates growth in planta and organogenesis in vitro 33
A pharmacological batch of Mongersen that downregulates Smad7 is effective as induction therapy in active Crohn's disease: a phase II, open-label study 32
Rafoxanide sensitizes colorectal cancer cells to TRAIL-mediated apoptosis 31
The Deubiquitinating Enzyme OTUD5 Sustains Inflammatory Cytokine Response in Inflammatory Bowel Disease 28
A Novel Smad7 Genetic Variant Mapping on the Genomic Region Targeted by Mongersen Is Associated with Crohn's Disease 25
Implication of Intestinal Barrier Dysfunction in Gut Dysbiosis and Diseases 24
Impact of food additives on gut homeostasis 22
A novel tumour enhancer function of Insulin-like growth factor II mRNA-binding protein 3 in colorectal cancer 21
Inhomogeneous Diastereomeric Composition of Mongersen Antisense Phosphorothioate Oligonucleotide Preparations and Related Pharmacological Activity Impairment 21
Folate-Functionalization Enhances Cytotoxicity of Multivalent DNA Nanocages on Triple-Negative Breast Cancer Cells 18
Rafoxanide sensitizes colorectal cancer cells to TRAIL-mediated apoptosis 15
Involvement of smad7 in inflammatory diseases of the gut and colon cancer 13
CDT1 drives replication overlicensing and enhances tumorigenesis in the gut† 9
Insulin-like Growth Factor II mRNA-Binding Protein 1 Regulates Pancreatic Cancer Cell Growth through the Surveillance of CDC25A mRNA 9
Hepcidin Upregulation in Colorectal Cancer Associates with Accumulation of Regulatory Macrophages and Epithelial–Mesenchymal Transition and Correlates with Progression of the Disease 8
Smad7 Antisense Oligonucleotide in Crohn’s Disease: A Re-Evaluation and Explanation for the Discordant Results of Clinical Trials 6
Helicobacter pylori and Gastric Cancer: Pathogenetic Mechanisms 6
Smad7 Antisense Oligonucleotide-Based Therapy in Crohn's Disease: Is it Time to Re-Evaluate? 5
Anthelmintic Drugs as Emerging Immune Modulators in Cancer 4
Targeted Therapy of Interleukin-34 as a Promising Approach to Overcome Cancer Therapy Resistance 4
Impact of Western Diet and Ultra-Processed Food on the Intestinal Mucus Barrier 4
TRAIL-Sensitizing Effects of Flavonoids in Cancer 4
null 3
Smad7 as a positive regulator of intestinal inflammatory diseases 3
Totale 20.885
Salva come PNG Salva come JPEG
Categoria #
all - tutte 42.289
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 42.289
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20191.102 0 0 0 0 0 0 0 0 0 0 565 537
2019/20205.455 461 445 386 456 426 608 515 492 492 457 323 394
2020/20213.998 310 387 849 455 337 438 420 360 87 174 120 61
2021/2022860 45 97 57 19 27 60 59 24 90 76 68 238
2022/20231.183 102 111 32 146 123 226 96 95 114 40 72 26
2023/2024396 56 18 26 16 48 119 20 84 4 5 0 0
Totale 20.885